查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1938737

2026年全球獸醫分子診斷市場報告

Veterinary Molecular Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，獸醫分子診斷市場成長顯著，預計到2025年將達到7億美元，到2026年將達到7.7億美元，複合年成長率為9.9%。過去幾年的成長可歸因於多種因素，例如動物感染疾病和遺傳疾病的增加、分子生物學領域的技術進步、伴侶動物和牲畜數量的成長、獸醫意識和教育的提高以及傳統分子診斷試劑盒的普及應用。

預計未來幾年，獸醫分子診斷市場將維持強勁成長，2030年市場規模將達到11.1億美元，複合年成長率（CAGR）為9.6%。預測期內的成長要素包括：對快速、準確的分子診斷需求不斷成長；次世代定序（NGS）和高通量平台的日益普及；獸醫基因組學服務的擴展；人工智慧驅動的診斷分析的整合；以及對透過分子檢測進行預防性獸醫保健的日益重視。預測期內的主要趨勢包括：基於PCR和RT-PCR的診斷方法的擴展；獸醫學領域次世代定序（NGS）技術的日益普及；感染疾病多重診斷試劑盒的開發；分子診斷技術融入常規獸醫保健；以及自動化和高通量分子檢測解決方案的廣泛應用。

預計未來通用感染疾病的高發將推動獸醫分子診斷市場的成長。通用感染疾病是由細菌、病毒、寄生蟲或真菌引起的感染疾病，可在動物和人類之間傳播。典型的例子包括狂犬病、萊姆病、沙門氏菌病和弓形蟲病。這些疾病的流行受到多種因素的影響，例如森林砍伐、野生動物過度開發、密集畜牧業、生物多樣性喪失和人口流動。獸醫分子診斷技術能夠早期檢測動物體內的通用感染疾病，透過快速且準確地鑑定病原體，有助於預防人類感染並加強疾病控制。例如，根據總部位於瑞典的政府機構－歐洲疾病預防控制中心（ECDC）2025年12月發布的報告，2024年報告的主要通用感染疾病病例數（曲狀桿菌：168,396例，沙門氏菌病：79,703例等）持續增加，凸顯了通用感染疾病在歐洲的持續蔓延。因此，通用感染疾病的高發生率正在推動獸醫分子診斷市場的發展。

獸醫分子診斷市場的主要企業正致力於診斷技術的自動化和擴充性，例如高通量檢測設備，以提高診斷準確性、簡化檢測流程並快速檢測動物疾病。高通量檢測設備是一種先進的診斷設備，能夠有效率地處理大量檢體，支援實驗室和臨床環境中的快速且準確分析，尤其適用於大規模檢測。例如，2023年6月，美國愛荷華州立大學獸醫診斷實驗室（VDL）推出了SmartChip分子診斷設備，該設備採用定量聚合酵素鏈鎖反應（qPCR）技術。該設備可在郵票大小的微孔板上容納超過5000個檢體，並可與具有自動化處理功能的384檢體系統結合使用，進一步提高檢測通量。 SmartChip利用微流體技術，只需標準96孔盤百分之一的樣本量即可高效識別目標病原體。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球獸醫分子診斷市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • PCR和RT-PCR診斷方法的擴展
    • 獸醫學領域對次世代定序（NGS）技術的日益普及
    • 開發用於感染疾病的多重診斷試劑盒
    • 將分子診斷技術整合到常規獸醫護理中
    • 自動化高通量分子檢測解決方案

第5章 終端用戶產業市場分析

  • 診斷檢查室
  • 獸醫診所
  • 獸醫診所
  • 研究所
  • 學術和獸醫訓練中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球獸醫分子診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球獸醫分子診斷市場規模、比較及成長率分析
  • 全球獸醫分子診斷市場表現：規模與成長，2020-2025年
  • 全球獸醫分子診斷市場預測：規模與成長，2025-2030年，2035年

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品
  • 試劑盒、試劑和設備
  • 依動物類型
  • 伴侶動物、牲畜
  • 透過使用
  • 感染疾病、遺傳性疾病及其他用途
  • 最終用戶
  • 診斷檢查室、動物診所、獸醫醫院和其他終端用戶
  • 按類型細分：試劑盒和試劑
  • 聚合酵素鏈鎖反應(PCR) 試劑盒、逆轉錄聚合酵素鏈鎖反應(RT-PCR) 試劑盒、即時PCR盒、核酸萃取試劑盒、酵素免疫分析法(ELISA) 試劑盒、雜合反應盒和次世代定序(NGS) 試劑
  • 按類型細分：設備
  • PCR設備（聚合酵素連鎖反應熱迴圈儀）、即時PCR設備、核酸分析設備、凝膠電泳設備、DNA定序儀、自動化液體處理系統、分子影像系統

第10章 區域與國家分析

  • 全球獸醫分子診斷市場：依地區、績效及預測分類，2020-2025年、2025-2030年、2035年
  • 全球獸醫分子診斷市場：依國家、績效及預測分類，2020-2025年、2025-2030年、2035年

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 獸醫分子診斷市場：競爭格局與市場佔有率（2024 年）
  • 獸醫分子診斷市場：公司估值矩陣
  • 獸醫分子診斷市場：公司概況
    • Roche Diagnostics Corporation
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Zoetis Inc.
    • Illumina Inc.

第37章：其他領先和創新企業

  • PerkinElmer Inc., bioMerieux SA, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN NV, LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek BV, Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年獸醫分子診斷市場：提供新機會的國家
  • 2030年獸醫分子診斷市場：充滿新機會的細分市場
  • 2030年獸醫分子診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: VH4MVMDO01_G26Q1

Veterinary molecular diagnostics involves the use of molecular biology techniques to identify and diagnose animal diseases at the genetic or molecular level. These diagnostics detect specific pathogens (such as bacteria, viruses, or parasites), genetic mutations, or biomarkers that signal disease, assisting veterinarians in making precise diagnoses and treatment plans.

The main products in veterinary molecular diagnostics include kits, reagents, and instruments. Kits and reagents are crucial for conducting various diagnostic tests on animal samples in laboratories and industrial settings, providing accurate and reliable results necessary for effective treatment and management of diseases. These diagnostics are applicable to both companion animals and livestock, addressing conditions such as infectious and genetic diseases. The primary users of these products are diagnostic laboratories, veterinary clinics, veterinary hospitals, and similar facilities.

Tariffs have impacted the veterinary molecular diagnostics market by increasing the cost of imported kits, reagents, and advanced instruments such as PCR machines and DNA sequencers, affecting pricing and accessibility for diagnostic laboratories and veterinary clinics. Segments like kits and reagents and instruments are most affected, particularly in regions such as North America and Europe reliant on imports. However, tariffs have also stimulated local manufacturing, encouraged development of cost-effective diagnostic solutions, and fostered regional innovation in molecular veterinary diagnostics.

The veterinary molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides veterinary molecular diagnostics market statistics, including veterinary molecular diagnostics industry global market size, regional shares, competitors with a veterinary molecular diagnostics market share, detailed veterinary molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary molecular diagnostics industry. This veterinary molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary molecular diagnostics market size has grown strongly in recent years. It will grow from $0.7 billion in 2025 to $0.77 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing prevalence of infectious and genetic animal diseases, technological advancements in molecular biology, growth of companion and livestock animal populations, rising veterinary awareness and training, adoption of conventional molecular diagnostic kits.

The veterinary molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to rising demand for rapid and accurate molecular diagnostics, adoption of ngs and high-throughput platforms, expansion of veterinary genomics services, integration of ai-driven diagnostic analysis, growing emphasis on preventive veterinary care through molecular testing. Major trends in the forecast period include expansion of pcr and rt-pcr-based diagnostics, growing adoption of next-generation sequencing (ngs) in veterinary medicine, development of multiplex diagnostic kits for infectious diseases, integration of molecular diagnostics in routine veterinary care, automation and high-throughput molecular testing solutions.

The high prevalence of zoonotic diseases is expected to drive the growth of the veterinary molecular diagnostics market going forward. Zoonotic diseases are infectious conditions transmitted between animals and humans, caused by bacteria, viruses, parasites, or fungi. Common examples include rabies, Lyme disease, salmonellosis, toxoplasmosis, and more. The prevalence of these diseases is influenced by factors such as deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility. Veterinary molecular diagnostics enable early detection of zoonotic diseases in animals, preventing transmission to humans and improving disease management through rapid and accurate pathogen identification. For example, in December 2025, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, the number of reported human cases of key zoonotic diseases in 2024-such as campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases)-continued to rise, highlighting the ongoing prevalence of zoonoses in Europe. Therefore, the high prevalence of zoonotic diseases is driving the veterinary molecular diagnostics market.

Leading players in the veterinary molecular diagnostics market are focusing on automation and scalability in diagnostic technologies, such as high-volume testing machines, to enhance diagnostic accuracy, increase testing efficiency, and enable faster disease detection in animals. High-volume testing machines are advanced diagnostic devices capable of processing large numbers of samples efficiently, supporting rapid and accurate analysis in laboratory or clinical settings, especially for large-scale testing. For instance, in June 2023, Iowa State University's Veterinary Diagnostic Laboratory (VDL), a US-based university, introduced SmartChip, a molecular diagnostic device utilizing quantitative polymerase chain reaction (qPCR) technology. This device can accommodate over 5,000 samples on a plate no larger than a postage stamp, and its capacity increases further when paired with a 384-sample system featuring automated handling. SmartChip employs microfluidic technology, using a sample volume 100 times smaller than standard 96-well machines, to identify targets of interest efficiently.

In April 2023, Mars Incorporated, a US-based diversified manufacturing and petcare company, acquired Heska Corporation for approximately $1.3 billion. Through this acquisition, Mars aimed to strengthen and expand its petcare science and diagnostics capabilities by broadening its veterinary diagnostic offerings and accelerating innovation in point-of-care solutions for the global pet healthcare market. Heska Corporation is a US-based healthcare technology company specializing in the development, manufacture, marketing, and support of advanced veterinary diagnostic and specialty products for veterinary practitioners worldwide.

Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMerieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.

North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary molecular diagnostics market consists of revenues earned by entities by providing services such as diagnostic testing services, surveillance testing, genetic testing, toxicology, and biocompatibility testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary molecular diagnostics market also includes sales of immunoassay kits, diagnostic software, and next-generation sequencing (NGS) systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Molecular Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Kits And Reagents; Instruments
  • 2) By Animal Type: Companion Animals; Livestock Animals
  • 3) By Application: Infectious Diseases; Genetic Diseases; Other Applications
  • 4) By End-User: Diagnostic Laboratories; Veterinary Clinics; Veterinary Hospitals; Other End-Users
  • Subsegments:
  • 1) By Kits And Reagents: Polymerase Chain Reaction (PCR) Kits; Reverse Transcription PCR (RT-PCR) Kits; Real-Time PCR Kits; Nucleic Acid Extraction Kits; Enzyme-Linked Immunosorbent Assay (ELISA) Kits; Hybridization Kits; Reagents For Next-Generation Sequencing (NGS)
  • 2) By Instruments: PCR Machines (Thermal Cyclers); Real-Time PCR Machines; Nucleic Acid Analyzers; Gel Electrophoresis Equipment; DNA Sequencers; Automated Liquid Handling Systems; Molecular Imaging Systems
  • Companies Mentioned: Roche Diagnostics Corporation; Thermo Fisher Scientific Inc.; Merck KGaA; Zoetis Inc.; Illumina Inc.; PerkinElmer Inc.; bioMerieux S.A.; IDEXX Laboratories Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; LGC Group Ltd.; Neogen Corporation; Abcam plc; Eiken Chemical Co. Ltd.; Bioneer Corporation; INDICAL BIOSCIENCE GmbH; Biochek B.V.; Ring Biotechnology Co. Ltd.; Ingenetix GmbH; MiDOG Animal Diagnostics LLC; Biolab S.r.l.; Bionote USA Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Veterinary Molecular Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Veterinary Molecular Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Veterinary Molecular Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Veterinary Molecular Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Biotechnology, Genomics & Precision Medicine
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Expansion Of Pcr And Rt-Pcr-Based Diagnostics
    • 4.2.2 Growing Adoption Of Next-Generation Sequencing (Ngs) In Veterinary Medicine
    • 4.2.3 Development Of Multiplex Diagnostic Kits For Infectious Diseases
    • 4.2.4 Integration Of Molecular Diagnostics In Routine Veterinary Care
    • 4.2.5 Automation And High-Throughput Molecular Testing Solutions

5. Veterinary Molecular Diagnostics Market Analysis Of End Use Industries

  • 5.1 Diagnostic Laboratories
  • 5.2 Veterinary Clinics
  • 5.3 Veterinary Hospitals
  • 5.4 Research Institutes
  • 5.5 Academic And Veterinary Training Centers

6. Veterinary Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Veterinary Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Veterinary Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Veterinary Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Veterinary Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary Molecular Diagnostics Market Segmentation

  • 9.1. Global Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Kits And Reagents, Instruments
  • 9.2. Global Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Companion Animals, Livestock Animals
  • 9.3. Global Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infectious Diseases, Genetic Diseases, Other Applications
  • 9.4. Global Veterinary Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users
  • 9.5. Global Veterinary Molecular Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents For Next-Generation Sequencing (NGS)
  • 9.6. Global Veterinary Molecular Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

10. Veterinary Molecular Diagnostics Market Regional And Country Analysis

  • 10.1. Global Veterinary Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Veterinary Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary Molecular Diagnostics Market

  • 11.1. Asia-Pacific Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary Molecular Diagnostics Market

  • 12.1. China Veterinary Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary Molecular Diagnostics Market

  • 13.1. India Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary Molecular Diagnostics Market

  • 14.1. Japan Veterinary Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary Molecular Diagnostics Market

  • 15.1. Australia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary Molecular Diagnostics Market

  • 16.1. Indonesia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary Molecular Diagnostics Market

  • 17.1. South Korea Veterinary Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary Molecular Diagnostics Market

  • 18.1. Taiwan Veterinary Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary Molecular Diagnostics Market

  • 19.1. South East Asia Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary Molecular Diagnostics Market

  • 20.1. Western Europe Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary Molecular Diagnostics Market

  • 21.1. UK Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary Molecular Diagnostics Market

  • 22.1. Germany Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary Molecular Diagnostics Market

  • 23.1. France Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary Molecular Diagnostics Market

  • 24.1. Italy Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary Molecular Diagnostics Market

  • 25.1. Spain Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary Molecular Diagnostics Market

  • 26.1. Eastern Europe Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary Molecular Diagnostics Market

  • 27.1. Russia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary Molecular Diagnostics Market

  • 28.1. North America Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary Molecular Diagnostics Market

  • 29.1. USA Veterinary Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary Molecular Diagnostics Market

  • 30.1. Canada Veterinary Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary Molecular Diagnostics Market

  • 31.1. South America Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary Molecular Diagnostics Market

  • 32.1. Brazil Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary Molecular Diagnostics Market

  • 33.1. Middle East Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary Molecular Diagnostics Market

  • 34.1. Africa Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary Molecular Diagnostics Market Regulatory and Investment Landscape

36. Veterinary Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Veterinary Molecular Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Veterinary Molecular Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Veterinary Molecular Diagnostics Market Company Profiles
    • 36.3.1. Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary Molecular Diagnostics Market Other Major And Innovative Companies

  • PerkinElmer Inc., bioMerieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC

38. Global Veterinary Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Molecular Diagnostics Market

40. Veterinary Molecular Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Veterinary Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Veterinary Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Veterinary Molecular Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer